Related to Aileron to Leverage Scripps’ Click Chemistry to Develop Peptide and Protein Therapeutics

• Athera Signs On Richter-Helm to Produce Cardiovascular Protein Therapeutic
  
• Lentigen and Expression Therapeutics to Develop Hemophilia A Therapies
  
• Ferring Opens San Diego Center for Peptide Research
  
• Cyclogenix Inks License and Research Deals Wyeth and IMBcom to Further Peptide Research
  
• Phylogica to Offer Peptide Candidates Delivered with Aegis’ Nasal Spray Technology
  
• Zealand Pharma to Test Vyteris’ Patch with Its Peptide Drugs
  
• Maxygen and Astellas Create JV to Advance Former’s Protein-Based Drug Program
  
• Medarex Taps Lonza for Biomanufacturing
  
• Ambrx and Wyeth Sign Multitarget Alliance to Develop Protein Drugs
  
• Scripps-Led Consortium that Combines Physics and Oncology Receives $10M
  
• Altea Therapeutics’ Transdermal Delivery Technology to Be Tested with KAI Pharmaceuticals’ Peptides
  
• Genzyme and Arecor Ally to Advance Protein Therapeutics
  
• Virdante Taps ProBioGen for Cell-Line Development
  
• Scripps Team Finds Natural Redox Biochemistry Drives Stem Cell Differentiation
  
• RegeneRx Wins $3M Award to Advance Peptide Therapeutic for Heart Attack
  
• Spanish Plasma Proteins Group Grifols Acquires Talecris for $3.4B
  
• Asterand to Help Amylin Identify Compounds for the Treatment of Inflammatory Diseases
  
• MonoSol Takes Equity Stake in Midatech as Firms Work to Combine Thin Film and Nanoparticle Therapeutics Technologies
  
• Perseid Obtains $5M with Preclinical Success under Partnership with Astellas
  
• Anchor Raises $10M in Series B to Progress Preclinical GPCR-Targeting Pepducin Drugs